Nonprofit · EIN 53-0241211
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Tax-exempt · WASHINGTON, DC 20024
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $521,348,217 | $578,265,057 | -$56,916,840 | $349,012,370 | $190,475,115 | $158,537,255 |
| December 31, 2023 | 990 | $483,040,082 | $426,549,040 | $56,491,042 | $398,950,677 | $188,021,710 | $210,928,967 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $1,116,000
- Program service revenue
- $507,993,172
- Investment income
- $11,851,925
- Net gain from sales of assets
- -$69,780
- Other revenue
- $387,120
Expenses
- Grants and similar amounts paid
- $43,264,315
- Compensation of officers, directors and key employees
- $23,765,282
- Other salaries and wages
- $71,694,936
- Salaries, compensation and benefits (total)
- $113,002,505
- Professional fundraising fees
- $0
- Legal fees
- $20,599,243
- Accounting fees
- $315,609
- Occupancy
- $13,985,438
- Travel
- $4,809,997
- Depreciation
- $3,399,116
Balance sheet and other
- Total assets, start of year
- $398,950,677
- Total assets, end of year
- $349,012,370
- Total liabilities, end of year
- $190,475,115
- Net assets, end of year
- $158,537,255
- Land, buildings and equipment
- $30,519,414
- Publicly traded securities
- $90,734,870
- Net assets without donor restrictions
- $158,537,255
- Gross receipts
- $524,889,625
- Employees
- 300
- Volunteers
- 3,789
- Year formed
- 1958
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| Stephen J Ubl | President & CEO Trustee or director, Officer | 37.5 | $5,935,826 | $1,707,190 |
| Lori Reilly | COO Key employee | 37.5 | $2,547,833 | $1,975,518 |
| James C Stansel | General Counsel & EVP Law, Secretary Officer | 37.5 | $1,761,157 | $505,701 |
| Anne Pritchett | SVP, Policy/Research Highest-paid employee | 37.5 | $2,066,592 | $39,615 |
| Steven Tilton | EVP, Federal Advocacy Key employee | 37.5 | $920,326 | $988,240 |
| Robert Zirkelbach II | EVP, Public Affairs Key employee | 37.5 | $1,190,211 | $691,431 |
| Jennifer Bryant | EVP, Policy/Research Former | 37.5 | $1,858,936 | $0 |
| Elizabeth Carpenter | EVP, Policy/Research Key employee | 37.5 | $1,077,102 | $677,009 |
| Tracey Merchant | CFO & EVP, Administration Officer | 37.5 | $1,340,588 | $376,568 |
| Scott LaGanga | EVP, State Advocacy Highest-paid employee | 37.5 | $1,199,864 | $374,645 |
| Shannon Monsif | EVP, Alliance Key employee | 37.5 | $1,115,048 | $363,936 |
| Michael Woody | SVP, Federal Advocacy Highest-paid employee | 37.5 | $1,175,941 | $288,740 |
| Jay Taylor | EVP, International Highest-paid employee | 37.5 | $990,116 | $348,569 |
| Kenneth K McKay IV | SVP, State Advocacy Highest-paid employee | 37.5 | $935,523 | $285,686 |
| Renuka Iyer | EVP, Human Resources Key employee | 37.5 | $652,356 | $285,806 |
35 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Albert Bourla PHD | VICE CHAIR Trustee or director, Officer | 2 | $0 |
| Daniel O' Day | CHAIR Trustee or director, Officer | 2 | $0 |
| Paul Hudson | TREASURER Trustee or director, Officer | 2 | $0 |
| Alexander Hardy | DIRECTOR Trustee or director | 2 | $0 |
| ANTHONY MANCINI | DIRECTOR (THRU 08/24) Trustee or director | 2 | $0 |
| Ashley Magargee | DIRECTOR Trustee or director | 2 | $0 |
| Barry Greene | DIRECTOR Trustee or director | 2 | $0 |
| Bob Lojewski | DIRECTOR Trustee or director | 2 | $0 |
| Brad Bailey | DIRECTOR (AS OF 08/24) Trustee or director | 2 | $0 |
| Chris Boerner PHD | DIRECTOR Trustee or director | 2 | $0 |
| Chris ROUND | DIRECTOR (THRU 12/24) Trustee or director | 2 | $0 |
| Chris Viehbacher | DIRECTOR Trustee or director | 2 | $0 |
| David Loew | DIRECTOR Trustee or director | 2 | $0 |
| David Ricks | DIRECTOR Trustee or director | 2 | $0 |
| DOUGLAS L LANGA | DIRECTOR (THRU 12/24) Trustee or director | 2 | $0 |
| Emma Walmsley | DIRECTOR Trustee or director | 2 | $0 |
| Herve J Hoppenot | DIRECTOR Trustee or director | 2 | $0 |
| Jean-Christophe Tellier MD | DIRECTOR Trustee or director | 2 | $0 |
| Jean-Michel Boers | DIRECTOR Trustee or director | 2 | $0 |
| Jennifer Taubert | DIRECTOR Trustee or director | 2 | $0 |
| Julie Kim | DIRECTOR Trustee or director | 2 | $0 |
| Ken Keller | DIRECTOR Trustee or director | 2 | $0 |
| KEVIN C GORMAN PhD | DIRECTOR (THRU 09/24) Trustee or director | 2 | $0 |
| Kyle Gano PHD | DIRECTOR (AS OF 10/24) Trustee or director | 2 | $0 |
| MARK REISENAUER | DIRECTOR (THRU 04/24) Trustee or director | 2 | $0 |
| Michael Petroutsas | DIRECTOR (AS OF 02/24) Trustee or director | 2 | $0 |
| MYRTLE POTTER | DIRECTOR (THRU 03/24) Trustee or director | 2 | $0 |
| Richard F Pops | DIRECTOR Trustee or director | 2 | $0 |
| Robert A Bradway | DIRECTOR Trustee or director | 2 | $0 |
| Robert M Davis | DIRECTOR Trustee or director | 2 | $0 |
| Sebastian Guth PHD | DIRECTOR Trustee or director | 2 | $0 |
| Tarek Rabah | DIRECTOR Trustee or director | 2 | $0 |
| Tatsuyki Yasuno | DIRECTOR Trustee or director | 2 | $0 |
| Thomas Gibbs | DIRECTOR Trustee or director | 2 | $0 |
| Vasant Vas Narasimhan MD | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended December 31, 2023: 47 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| STEPHEN J UBL | PRESIDENT & CEO Trustee or director, Officer | 37.5 | $5,053,582 | $1,653,862 |
| LORI REILLY | COO Key employee | 37.5 | $2,233,732 | $656,619 |
| JENNIFER BRYANT | EVP, POLICY/RESEARCH Key employee | 37.5 | $2,471,035 | $75,301 |
| JAMES C STANSEL | GEN COUNSEL & EVP LAW, SECY Officer | 37.5 | $1,658,117 | $540,693 |
| ANNE ESPOSITO | SVP, FEDERAL ADVOCACY Highest-paid employee | 37.5 | $949,522 | $1,117,631 |
| SCOTT LAGANGA | EVP, STATE ADVOCACY Highest-paid employee | 37.5 | $1,171,708 | $372,572 |
| TRACEY MERCHANT | CFO & EVP, ADMINISTRATION Officer | 37.5 | $1,124,704 | $369,597 |
| ROBERT ZIRKELBACH II | EVP, PUBLIC AFFAIRS Key employee | 37.5 | $1,025,001 | $370,547 |
| SHANNON C MONSIF | EVP, ADVOCACY & STRATEGIC ALL Key employee | 37.5 | $1,047,384 | $309,960 |
| ANNE M PRITCHETT | SVP, POLICY/RESEARCH Highest-paid employee | 37.5 | $1,007,339 | $247,782 |
| JAY TAYLOR | EVP, INTERNATIONAL Highest-paid employee | 37.5 | $938,748 | $297,850 |
| KENNETH K MCKAY IV | SVP, STATE ADVOCACY Highest-paid employee | 37.5 | $892,286 | $277,672 |
| ELIZABETH CARPENTER | EVP, POLICY/RESEARCH Key employee | 37.5 | $440,346 | $335,023 |
| RENUKA IYER | EVP, HUMAN RESOURCES Key employee | 37.5 | $397,692 | $222,340 |
| RICHARD MOSCICKI MD | CMO & EVP, SCIENCE/REG ADVOCAC Former | 37.5 | $597,574 | $0 |
| PAUL A AINES | CFO & EVP, ADMINISTRATION Former | 37.5 | $581,484 | $0 |
| ROBIN E PALCHUS | SVP, HUMAN RESOURCES Former | 37.5 | $289,277 | $0 |
| VASANT VAS NARASIMHAN MD | CHAIRMAN Trustee or director, Officer | 2 | $0 | $0 |
| DANIEL O'DAY | VICE CHAIRMAN Trustee or director, Officer | 2 | $0 | $0 |
| CHRIS BOERNER PHD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JEAN-MICHEL BOERS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ALBERT BOURLA | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| ROBERT BRADWAY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ROBERT M DAVIS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| THOMAS GIBBS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| BARRY GREENE | DIRECTOR Trustee or director | 2 | $0 | $0 |
| SEBASTIAN GUTH PHD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ALEXANDER HARDY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| HERVE J HOPPENOT | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KEN KELLER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JULIE KIM | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DOUGLAS J LANGA | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DAVID LOEW | DIRECTOR Trustee or director | 2 | $0 | $0 |
| BOB LOJEWSKI | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RICHARD F POPS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MYRTLE POTTER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| TAREK RABAH | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARK REISENAUER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DAVID RICKS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| CHRIS ROUND | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JENNIFER TAUBERT | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JEAN-CHRISTOPHE TELLIER MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| CHRIS VIEHBACHER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| EMMA WALMSLEY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| TATSUYKI YASUNO | DIRECTOR Trustee or director | 2 | $0 | $0 |
| Paul Hudson | DIRECTOR Trustee or director | 2 | $0 | $0 |
| Jean-Jaques Bienaime | DIRECTOR Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 670 MAINE AVE SW, WASHINGTON, DC 20024-3556
- In care of
- % TRACEY MERCHANT CFO/EVP
- Principal officer (990 for 2024)
- STEPHEN J UBL, 670 MAINE AVENUE SW 1000, WASHINGTON, DC 200243556
- Signed the 990
- STEPHEN J UBL, PRESIDENT & CEO
- Phone
- (202) 835-3400
- Website
- WWW.PHRMA.ORG
- Return prepared by
- BDO USA
Mission
PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF IMPORTANT, NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES.
Program accomplishments
- PUBLIC POLICY ADVOCACY: PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES. PHRMA ACHIEVES THIS MISSION BY WORKING WITH, AND ON BEHALF OF, ITS MEMBER COMPANIES BEFORE GOVERNMENTAL AND REGULATORY BODIES IN THE UNITED STATES AND THROUGHOUT THE WORLD IN SUPPORT OF PRO-PATIENT, PRO-INNOVATION POLICIES. SPECIFICALLY, PHRMA ADVOCATES FOR BROAD PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICINES THROUGH A FREE MARKET, WITHOUT GOVERNMENT PRICE CONTROLS; STRONG INTELLECTUAL PROPERTY INCENTIVES; AND TRANSPARENT, EFFICIENT REGULATION AND A FREE FLOW OF INFORMATION TO PATIENTS.
- MEMBER SERVICES: IN REPRESENTING THE COUNTRY'S LEADING PHARMACEUTICAL RESEARCH AND BIOTECHNOLOGY COMPANIES, PHRMA PROVIDES A FORUM FOR MEMBER COMPANIES TO PARTICIPATE IN DISCUSSIONS OF RELEVANT HEALTH CARE ISSUES AND TO DEVELOP CONSENSUS POSITIONS ON MATTERS OF PUBLIC POLICY ADVOCACY. MEMBER COMPANIES PARTICIPATE IN PHRMA ACTIVITIES THROUGH REPRESENTATION ON THE BOARD OF DIRECTORS, BOARD-LEVEL COMMITTEES, STAFF WORK GROUPS, SECTIONS, AND TASK FORCES. MEMBER COMPANY REPRESENTATIVES ALSO REGULARLY COMMUNICATE WITH PHRMA STAFF.
- GENERAL EDUCATION ABOUT BIOPHARMACEUTICAL INDUSTRY: PHRMA DISSEMINATES INFORMATION ABOUT BIOPHARMACEUTICAL COMPANIES, THEIR PRODUCTS, AND THEIR BUSINESS, SCIENTIFIC AND PHILANTHROPIC ACTIVITIES THROUGH A WIDE RANGE OF CHANNELS, INCLUDING PROFILES, REPORTS, PRINCIPLES, GUIDELINES, FACT SHEETS, POLICY PAPERS AND OTHER RESOURCES. THESE EFFORTS BOLSTER PHRMA'S ABILITY TO EDUCATE AND INFORM MEMBERS OF THE GENERAL PUBLIC AS WELL AS POLICYMAKERS, THE MEDIA, PATIENTS AND OTHERS IN THE HEALTH CARE COMMUNITY ABOUT THE BIOPHARMACEUTICAL INDUSTRY AND PHRMA'S PUBLIC POLICY ACTIVITIES IN PARTICULAR.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 53-0241211
- Tax-exempt status
- 501(c)(6): Business league or chamber of commerce
- Donations deductible
- No
- Exempt since
- 1959
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $349,012,370
- Income (IRS master file)
- $524,889,625
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $521,348,217 | $578,265,057 | $349,012,370 | XML |
| 990 | December 2023 | $483,040,082 | $426,549,040 | $398,950,677 | XML |
| 990 | December 2022 | $568,384,699 | $574,376,853 | $286,234,000 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 53-0241211).
Questions about PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
- What is the EIN of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA?
- The employer identification number (EIN) of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is 53-0241211.
- Is PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 1959.
- Are donations to PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA tax-deductible?
- No. The IRS master file says contributions to it are not deductible.
- Which annual return does PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA?
- The 990 for the year ended December 31, 2024 names STEPHEN J UBL.
- Who are the officers and directors of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA?
- The 990 for the year ended December 31, 2024 lists 50 people; 15 received compensation from the organization, the highest $5,935,826 (Stephen J Ubl, President & CEO).
- How much revenue does PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $521,348,217, expenses of $578,265,057 and total assets of $349,012,370 at year end.
Other nonprofits in WASHINGTON
- AARP EIN 95-1985500 · last filed 990 for 2024
- RISANT HEALTH INC EIN 92-3467590 · last filed 990 for 2024
- AMERICAN NATIONAL RED CROSS EIN 53-0196605 · last filed 990 for 2025
- GAVI ALLIANCE EIN 98-0593375 · last filed 990 for 2024
- GEORGETOWN UNIVERSITY EIN 53-0196603 · last filed 990 for 2025
- NATIONAL ASSOCIATION OF LETTER CARRIERS EIN 53-0114650 · last filed 990-N for 2025
- SMITHSONIAN INSTITUTE EIN 53-0206027 · last filed 990 for 2025
- CHILDRENS HOSPITAL EIN 53-0196580 · last filed 990 for 2025